BMNR's 4.9% ETH Stake Underscores Concentration, Not Necessarily Value

What happened

Fool article reports BMNR now holds 4.9% of all ETH in circulation, equivalent to roughly 5.8 million tokens, confirming the company's aggressive treasury accumulation. This milestone follows nearly $12 billion in equity financing over nine months, which funded purchases but also expanded share count by over 340 million shares. While staking revenue has grown to $45.7 million per quarter, it remains 98% internal, offering little proof of a third-party franchise. Governance red flags persist, including ineffective disclosure controls and a capital structure with preferred dividends that could force dilution or asset sales in a downturn. The master report's WAIT rating remains appropriate: the headline is impressive, but the stock is still a leveraged bet on ETH without a clear margin of safety.

Implication

Investors should not confuse treasury size with business quality; BMNR's value is still dominated by ETH price and financing reflexes. The 4.9% stake increases concentration risk if ETH falls, as the balance sheet and liquidity are already stressed. Near-term upside depends on halting dilution and demonstrating third-party staking adoption, neither of which is assured. A decline toward $15 would offer a more attractive entry relative to asset value, while a rise above $23 would overprice unproven operating traction. Until governance and control weaknesses are remediated, position sizing should remain modest.

Thesis delta

The news does not alter the existing WAIT thesis; it reinforces the concentration on Ethereum and the company's reliance on capital markets. If anything, holding 4.9% of circulating ETH raises reflexive risk because a forced sale would move the market. No upgrade is warranted until share count stabilizes and MAVAN shows external clients.